Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-coronary Adenosine for Post-Stenting Myonecrosis
NCT00612521Phase 3Terminated
- Sponsor
- University of Ottawa Heart Institute
- Start
- Aug 2007
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronary artery disease (CAD) comparing Adenosine with Placebo (2 arms). Primary endpoint: Peri-procedural myocardial infarction. Started Aug 2007; status: terminated.
02
Drugs
adenosine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00612521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612521.